CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia.
View / Open Files
Authors
Guerrero, Jose A
Stritt, Simon
Mifsud, Richard W
Baig, Ayesha
Mueller, Annett
Evans, Amanda L
Hoffman, Gary J
Publication Date
2022-04-07Journal Title
Blood
ISSN
0006-4971
Publisher
American Society of Hematology
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Bennett, C., Lawrence, M., Guerrero, J. A., Stritt, S., Waller, A. K., Yan, Y., Mifsud, R. W., et al. (2022). CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia.. Blood https://doi.org/10.1182/blood.2021013113
Abstract
The process of platelet production has so far been understood to be a 2-stage process: megakaryocyte maturation from hematopoietic stem cells followed by proplatelet formation, with each phase regulating the peripheral blood platelet count. Proplatelet formation releases into the bloodstream beads-on-a-string preplatelets, which undergo fission into mature platelets. For the first time, we show that preplatelet maturation is a third, tightly regulated, critical process akin to cytokinesis that regulates platelet count. We show that deficiency in cytokine receptor-like factor 3 (CRLF3) in mice leads to an isolated and sustained 25% to 48% reduction in the platelet count without any effect on other blood cell lineages. We show that Crlf3-/- preplatelets have increased microtubule stability, possibly because of increased microtubule glutamylation via the interaction of CRLF3 with key members of the Hippo pathway. Using a mouse model of JAK2 V617F essential thrombocythemia, we show that a lack of CRLF3 leads to long-term lineage-specific normalization of the platelet count. We thereby postulate that targeting CRLF3 has therapeutic potential for treatment of thrombocythemia.
Keywords
StemCellInsitute
Sponsorship
Wellcome Trust (203151/Z/16/Z)
British Heart Foundation (None)
Medical Research Council (MR/R015724/1)
Medical Research Council (MR/V005413/1)
Medical Research Council (MC_PC_17230)
Identifiers
External DOI: https://doi.org/10.1182/blood.2021013113
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331195
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk